Jason Hsu, Director at Immix Biopharma, Inc. (IMMX), bought 10,000 shares at $2.53 ($25K) on 2023-09-08, disclosed to the SEC on 2023-09-12.
Open-market purchase of $25k IMMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| IMMX | BUY | 2024-07-31 | $20K | — | Filing → |
| IMMX | BUY | 2023-12-12 | $267K | — | Filing → |
| IMMX | BUY | 2023-09-18 | $200K | — | Filing → |